D-0120
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for D-0120, covering 2022-05-06 to 2025-05-08. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Study to Evaluate Efficacy and Safety of D-0120 in Combination With Allopurinol in Subjects With Gout [Phase 2]